Cibc Private Wealth Group, LLC Co Diagnostics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,661 shares of CODX stock, worth $1,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,661
Previous 1,661
-0.0%
Holding current value
$1,727
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
4.28MCall Options Held
48.2KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.85 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny568KShares$590,4300.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$522,1060.0% of portfolio
-
Geode Capital Management, LLC Boston, MA321KShares$334,1260.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$283,8160.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $35.1M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...